Will significantly enhance service to researchers and institutions across China.
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, is expanding the scope and ...
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...
Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...
SK pharmteco, a global contract development and manufacturing organization (CDMO), has launched an enhanced analytical testing laboratory specifically dedicated to High Potency Active Pharmaceutical ...
Demonstrates its commitment to safeguarding sensitive information and adhering to global standards.
To support the development of next-gen therapies, including GLP-1 drugs for diabetes and obesity.
The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
To develop OliX’s OLX75016 candidate primarily targeting metabolic-associated steatohepatitis (MASH).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback